Edward Gunther - Publications

Affiliations: 
Cell and Molecular Biology Pennsylvania State University, State College, PA, United States 
Area:
Cell Biology, Molecular Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Li S, Gestl SA, Gunther EJ. A multistage murine breast cancer model reveals long-lived premalignant clones refractory to parity-induced protection. Cancer Prevention Research (Philadelphia, Pa.). PMID 31699706 DOI: 10.1158/1940-6207.CAPR-19-0322  0.412
2019 Keller RR, Gunther EJ. Evolution of Relapse-Proficient Subclones Constrained by Collateral Sensitivity to Oncogene Overdose in Wnt-Driven Mammary Cancer. Cell Reports. 26: 893-905.e4. PMID 30673612 DOI: 10.1016/j.celrep.2018.12.096  0.365
2016 Keller RR, Gestl SA, Lu AQ, Hoke A, Feith DJ, Gunther EJ. Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand bias. Carcinogenesis. PMID 27207659 DOI: 10.1093/Carcin/Bgw061  0.397
2014 Cleary AS, Leonard TL, Gestl SA, Gunther EJ. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature. 508: 113-7. PMID 24695311 DOI: 10.1038/nature13187  0.402
2012 Plichta KA, Mathers JL, Gestl SA, Glick AB, Gunther EJ. Basal but not luminal mammary epithelial cells require PI3K/mTOR signaling for Ras-driven overgrowth. Cancer Research. 72: 5856-66. PMID 23010075 DOI: 10.1158/0008-5472.Can-12-1635  0.523
2010 McHenry PR, Sears JC, Herrick MP, Chang P, Heckman-Stoddard BM, Rybarczyk M, Chodosh LA, Gunther EJ, Hilsenbeck SG, Rosen JM, Vargo-Gogola T. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. Breast Cancer Research : Bcr. 12: R73. PMID 20860838 DOI: 10.1186/Bcr2643  0.422
2008 Shen Q, Uray IP, Li Y, Zhang Y, Hill J, Xu XC, Young MR, Gunther EJ, Hilsenbeck SG, Colburn NH, Chodosh LA, Brown PH. Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumors. Cancer Prevention Research (Philadelphia, Pa.). 1: 45-55. PMID 19138935 DOI: 10.1158/1940-6207.Capr-08-0034  0.453
2008 Debies MT, Gestl SA, Mathers JL, Mikse OR, Leonard TL, Moody SE, Chodosh LA, Cardiff RD, Gunther EJ. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss. The Journal of Clinical Investigation. 118: 51-63. PMID 18060046 DOI: 10.1172/Jci33320  0.482
2007 Gestl SA, Leonard TL, Biddle JL, Debies MT, Gunther EJ. Dormant Wnt-initiated mammary cancer can participate in reconstituting functional mammary glands. Molecular and Cellular Biology. 27: 195-207. PMID 17060457 DOI: 10.1128/MCB.01525-06  0.736
2007 Jones RA, Campbell CI, Gunther EJ, Chodosh LA, Petrik JJ, Khokha R, Moorehead RA. Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation. Oncogene. 26: 1636-44. PMID 16953219 DOI: 10.1038/Sj.Onc.1209955  0.468
2003 Gunther EJ, Moody SE, Belka GK, Hahn KT, Innocent N, Dugan KD, Cardiff RD, Chodosh LA. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes & Development. 17: 488-501. PMID 12600942 DOI: 10.1101/Gad.1051603  0.476
2002 Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, Innocent N, Cardiff RD, Schnall MD, Chodosh LA. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2: 451-61. PMID 12498714 DOI: 10.1016/S1535-6108(02)00212-X  0.381
2001 D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nature Medicine. 7: 235-9. PMID 11175856 DOI: 10.1038/84691  0.495
Show low-probability matches.